Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia

M. Terwijn; A. Kelder; A.N. Snel; A.P. Rutten; W.J. Scholten; Y.J.M. Oussoren; A.A. van de Loosdrecht; S. Zweegman; G.J. Ossenkoppele; G.J. Schuurhuis

doi:https://doi.org/10.1111/j.1751-553X.2012.01416.x

Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia

M. Terwijn, A. Kelder, A.N. Snel, A.P. Rutten, W.J. Scholten, Y.J.M. Oussoren, A.A. van de Loosdrecht, S. Zweegman, G.J. Ossenkoppele, G.J. Schuurhuis

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	432-441
Journal	International journal of laboratory hematology
Volume	34
Issue number	4
DOIs	https://doi.org/10.1111/j.1751-553X.2012.01416.x
Publication status	Published - 2012

Access to Document

https://doi.org/10.1111/j.1751-553X.2012.01416.x

Cite this

Terwijn, M., Kelder, A., Snel, A. N., Rutten, A. P., Scholten, W. J., Oussoren, Y. J. M., van de Loosdrecht, A. A., Zweegman, S., Ossenkoppele, G. J., & Schuurhuis, G. J. (2012). Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia. International journal of laboratory hematology, 34(4), 432-441. https://doi.org/10.1111/j.1751-553X.2012.01416.x

@article{5f06a62dd2de435cbff7bd4799eb58f3,

title = "Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia",

author = "M. Terwijn and A. Kelder and A.N. Snel and A.P. Rutten and W.J. Scholten and Y.J.M. Oussoren and {van de Loosdrecht}, A.A. and S. Zweegman and G.J. Ossenkoppele and G.J. Schuurhuis",

year = "2012",

doi = "https://doi.org/10.1111/j.1751-553X.2012.01416.x",

language = "Undefined/Unknown",

volume = "34",

pages = "432--441",

journal = "International journal of laboratory hematology",

issn = "1751-5521",

publisher = "Wiley-Blackwell",

number = "4",

}

Terwijn, M, Kelder, A, Snel, AN, Rutten, AP, Scholten, WJ, Oussoren, YJM, van de Loosdrecht, AA , Zweegman, S , Ossenkoppele, GJ & Schuurhuis, GJ 2012, 'Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia', International journal of laboratory hematology, vol. 34, no. 4, pp. 432-441. https://doi.org/10.1111/j.1751-553X.2012.01416.x

Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia. / Terwijn, M.; Kelder, A.; Snel, A.N. et al.
In: International journal of laboratory hematology, Vol. 34, No. 4, 2012, p. 432-441.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia

AU - Terwijn, M.

AU - Kelder, A.

AU - Snel, A.N.

AU - Rutten, A.P.

AU - Scholten, W.J.

AU - Oussoren, Y.J.M.

AU - van de Loosdrecht, A.A.

AU - Zweegman, S.

AU - Ossenkoppele, G.J.

AU - Schuurhuis, G.J.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.1111/j.1751-553X.2012.01416.x

DO - https://doi.org/10.1111/j.1751-553X.2012.01416.x

M3 - Article

C2 - 22471741

SN - 1751-5521

VL - 34

SP - 432

EP - 441

JO - International journal of laboratory hematology

JF - International journal of laboratory hematology

IS - 4

ER -

Terwijn M, Kelder A, Snel AN, Rutten AP, Scholten WJ, Oussoren YJM et al. Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia. International journal of laboratory hematology. 2012;34(4):432-441. doi: https://doi.org/10.1111/j.1751-553X.2012.01416.x